{
  "cik": 1689375,
  "cik_padded": "0001689375",
  "entityName": "Entrada Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001689375-26-000011",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1041000.0,
        "cash": 90394000.0,
        "eps_diluted": -3.47,
        "free_cash_flow": -129553000.0,
        "net_income": -143750000.0,
        "operating_cash_flow": -128512000.0,
        "operating_income": -157898000.0,
        "revenue": 25421000.0,
        "stockholders_equity": 306133000.0,
        "total_assets": 377378000.0,
        "total_liabilities": 71245000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.23272564538942225,
        "revenue_growth_yoy": -0.8793967226803048,
        "roa_avg2y": -0.3181369017781363,
        "roa_period_end": -0.3809178065494014,
        "roe_avg2y": -0.39125707154628875,
        "roe_period_end": -0.4695671489189339
      }
    },
    {
      "accn": "0001689375-26-000011",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3158000.0,
        "cash": 101211000.0,
        "eps_diluted": 1.68,
        "free_cash_flow": -44715000.0,
        "net_income": 65626000.0,
        "operating_cash_flow": -41557000.0,
        "operating_income": 47011000.0,
        "revenue": 210782000.0,
        "stockholders_equity": 428678000.0,
        "total_assets": 526321000.0,
        "total_liabilities": 97643000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.22777702611283995,
        "net_margin": 0.3113453710468636,
        "operating_margin": 0.2230313783909442,
        "revenue_growth_yoy": 0.6338043452985358,
        "roa_avg2y": 0.13184358215312106,
        "roa_period_end": 0.1246881655871607,
        "roe_avg2y": 0.19559548043478908,
        "roe_period_end": 0.1530892651360695
      }
    },
    {
      "accn": "0001689375-26-000011",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5614000.0,
        "cash": 67602000.0,
        "eps_diluted": -0.2,
        "free_cash_flow": 134189000.0,
        "net_income": -6685000.0,
        "operating_cash_flow": 139803000.0,
        "operating_income": -3162000.0,
        "revenue": 129013000.0,
        "stockholders_equity": 242360000.0,
        "total_assets": 469192000.0,
        "total_liabilities": 226832000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.9359300214556857,
        "net_margin": -0.05181648361017882,
        "operating_margin": -0.024509157991830278,
        "roa_avg2y": -0.01853731310173477,
        "roa_period_end": -0.01424789851489369,
        "roe_avg2y": -0.029390170449799302,
        "roe_period_end": -0.027582934477636573
      }
    },
    {
      "accn": "0001689375-25-000011",
      "filed": "2025-02-27",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2887000.0,
        "cash": 45157000.0,
        "eps_diluted": -3.02,
        "free_cash_flow": -96673000.0,
        "net_income": -94616000.0,
        "operating_cash_flow": -93786000.0,
        "operating_income": -97248000.0,
        "stockholders_equity": 212554000.0,
        "total_assets": 252056000.0,
        "total_liabilities": 39502000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.18584453832908343,
        "roa_avg2y": -0.3391929218894798,
        "roa_period_end": -0.375376900371346,
        "roe_avg2y": -0.37012001439546854,
        "roe_period_end": -0.4451386471202612
      }
    },
    {
      "accn": "0001689375-24-000016",
      "filed": "2024-03-13",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 4580000.0,
        "cash": 291064000.0,
        "eps_diluted": -8.16,
        "free_cash_flow": -55442000.0,
        "net_income": -51158000.0,
        "operating_cash_flow": -50862000.0,
        "operating_income": -51127000.0,
        "stockholders_equity": 298718000.0,
        "total_assets": 305833000.0,
        "total_liabilities": 7115000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.02381845084661788,
        "roa_avg2y": -0.292866956720861,
        "roa_period_end": -0.1672742967567267,
        "roe_avg2y": -0.3977638515247174,
        "roe_period_end": -0.17125851137192938
      }
    },
    {
      "accn": "0001689375-23-000019",
      "filed": "2023-03-06",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2318000.0,
        "cash": 39045000.0,
        "eps_diluted": -24.0,
        "free_cash_flow": -27888000.0,
        "net_income": -26523000.0,
        "operating_cash_flow": -25570000.0,
        "operating_income": -26667000.0,
        "stockholders_equity": -41490000.0,
        "total_assets": 43527000.0,
        "total_liabilities": 3359000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.6093459232200703,
        "roe_avg2y": 0.9305009823182712
      }
    },
    {
      "accn": "0001558370-22-003614",
      "filed": "2022-03-15",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -15518000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001689375-26-000011",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001689375.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001689375.json"
  },
  "ticker": "TRDA"
}